Evidence map›Paper›PMID 39681916›Full record

ArticleBMC global and public health2024

Integration of HIV pre-exposure prophylaxis (PrEP) services for pregnant and breastfeeding women in eight primary care clinics: results of an implementation science study.

Aurelie Nelson, Kalisha Bheemraj, Sarah Schoetz Dean, Alex de Voux, Lerato Hlatshwayo, Rufaro Mvududu, Natacha Berkowitz, Caroline Neumuller, Shahida Jacobs, Stephanie Fourie and 4 more

Abstract read
In one paragraph

Article in BMC global and public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Aurelie NelsonDivision of Epidemiology & Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa. aurelie.nelson@gmail.com.
Kalisha BheemrajDivision of Epidemiology & Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa.
Sarah Schoetz DeanDivision of Infectious Diseases, Geffen School of Medicine, University of California Los Angeles, Los Angeles, USA.
Alex de VouxDivision of Epidemiology & Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa.
Lerato HlatshwayoDivision of Epidemiology & Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa.
Rufaro MvududuDivision of Epidemiology & Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa.
Natacha BerkowitzCity of Cape Town Department of Health, Cape Town, South Africa.
Caroline NeumullerCity of Cape Town Department of Health, Cape Town, South Africa.
Shahida JacobsWestern Cape Department of Health and Wellness, Metro Health Services, Klipfontein Mitchell's Plain Sub-Structure, Cape Town, South Africa.
Stephanie FourieWestern Cape Department of Health and Wellness, Metro Health Services, Klipfontein Mitchell's Plain Sub-Structure, Cape Town, South Africa.
Thomas CoatesDivision of Infectious Diseases, Geffen School of Medicine, University of California Los Angeles, Los Angeles, USA.
Linda Gail-BekkerDesmond Tutu Health Foundation, Cape Town, South Africa.
Landon MyerDivision of Epidemiology & Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa.
Dvora Joseph DaveyDivision of Epidemiology & Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa.

Funding

Evaluating the PrEP cascade in HIV-negative pregnant and breastfeeding women in South Africa (PrEP-PP)R01MH116771 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI JOSEPH DAVEY, DVORA LEAH, MYER, BENJAMIN LANDON · 2018 to 2022
$2.5M
Evaluation of pre-exposure prophylaxis cascade in pregnant and breastfeeding women in Cape Town, South AfricaK01TW011187 · FIC · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI JOSEPH DAVEY, DVORA LEAH · 2018 to 2022
$698k
FIC NIH HHS K01 TW011187Fogarty International K01TW011187National Institutes of Mental Health R01MH116771NIMH NIH HHS R01 MH116771
6 · The paper itself

Abstract

backgroundAlthough HIV vertical transmission has declined significantly in sub-Saharan Africa, incident HIV infection in pregnant and postpartum women is estimated to account for over one-third of HIV vertical transmission. Oral pre-exposure prophylaxis (PrEP) for pregnant and breastfeeding women (PBFW) is included in South African PrEP guidelines since 2021; however, integration of PrEP services within ante- and postnatal care remains limited.

methodsBetween March 2022 and September 2023, we evaluated the integration of PrEP for PBFW in eight antenatal clinics in Cape Town, South Africa, following training and mentorship of providers. We applied an adapted Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework to evaluate the integration of PrEP services for pregnant and breastfeeding women. Before the study, PrEP was not routinely offered. We implemented a staff didactic/practice-based training and mentorship on PrEP provision targeting PBFW. We evaluated the following: (1) Reach as the proportion of women initiating PrEP among women counselled and tested for HIV, (2) effectiveness as PrEP continuation up to 3 months by pregnant vs. breastfeeding women, (3) adoption of PrEP integration via pre- and post-training assessments and ongoing mentorship assessments, (4) implementation through clinic trends of PrEP offer over time, and (5) maintenance: continued PrEP offer 3 months following the intervention.

resultsIn 8 facilities providing ante- and postnatal care, we trained 224 healthcare providers (127 nurses and 37 counsellors). Of those, we mentored 60 nurses, midwives, and HIV counsellors working with pregnant and breastfeeding women, with 80% of nurse/midwives and 65% of counsellors scoring ≥ 80% on the final mentoring assessment. Overall, 12% of HIV-negative pregnant women started PrEP, and 41% of those continued PrEP up to 3 months. Among HIV-negative breastfeeding women, 14% initiated PrEP, and 25% continued PrEP up to 3 months. All eight facilities continued providing PrEP 3 months post intervention.

conclusionsIn these high HIV prevalence clinics, the proportion of pregnant and breastfeeding women initiating and continuing PrEP rapidly increased but was limited among breastfeeding women. Staff training, mentorship, and PrEP integration were well-adopted by nurses and counsellors, and services continued following the intervention. Barriers included limited HIV testing of breastfeeding mothers and need for additional PrEP-trained nurses.

Indexed as

HIVImplementation scienceMaternal and child healthPre-exposure prophylaxisVertical transmission

Identifiers

PMID39681916
PMCPMC11622949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.